Scott W. Andersen

4.8k citations
65 papers · 3.0k indexed · 3 hit papers · h-index 21
Topics
Alzheimer's disease research and treatments (24 papers)Treatment of Major Depression (18 papers)Dementia and Cognitive Impairment Research (17 papers)

In The Last Decade

Scott W. Andersen

62 papers receiving 2.9k citations

Hit Papers

Donanemab in ...1997202620062016202119972025250500750

Peers

Scott W. Andersen
Comparison fields: 5 of 114
  • Psychiatry and Mental health 1.8k
  • Physiology 1.1k
  • Pharmacology 812
  • Molecular Biology 348
  • Economics and Econometrics 282
Replace Hong Liu‐Seifert with:
Hong Liu‐Seifert United States
Gopalan Sethuraman United States
Michael Case United States
Lutz Froelich Germany
Lyn Harper Mozley United States
Dushyant P. Purohit United States
Michael Egan United States
Michelle Gee United Kingdom
Debby W. Tsuang United States
Edmond Teng United States
Scott W. Andersen relative to Hong Liu‐Seifert United States Hong Liu‐Seifert's profile →
Citations per field
00.5×9.5×
Hong Liu‐Seifert · 1×
Citations per year

Countries citing papers authored by Scott W. Andersen

Since Specialization
Citations

This map shows the geographic impact of Scott W. Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott W. Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott W. Andersen more than expected).

Fields of papers citing papers by Scott W. Andersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott W. Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott W. Andersen. The network helps show where Scott W. Andersen may publish in the future.

Co-authorship network of co-authors of Scott W. Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Scott W. Andersen. A scholar is included among the top collaborators of Scott W. Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott W. Andersen. Scott W. Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3
Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Diseasebreakdown →
29
4 17
5 8
6 8
7 2
8 13
9
Donanemab in Early Alzheimer’s Diseasebreakdown →
969
10 14
11 54
12 2
13 30
14 102
15 97
16 70
17 55
18 57
19 68
20
Double-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disordersbreakdown →
567

About Scott W. Andersen

Scott W. Andersen is a scholar working on Psychiatry and Mental health, Pharmacology and Physiology, having authored 65 papers that have together received 3.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (24 papers), Treatment of Major Depression (18 papers) and Dementia and Cognitive Impairment Research (17 papers). The work is most often cited by research in Psychiatry and Mental health (1.8k citations), Biological Psychiatry (223 citations) and Pharmacology (812 citations). Scott W. Andersen has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Gary D. Tollefson, John R. Sims, Pierre V. Trân, Mark A. Mintun, Cynthia Evans, Sergey Shcherbinin, Alette M. Wessels, S.H. Hamilton, Amy J. Kuntz and Charles M. Beasley. Their work appears in journals such as New England Journal of Medicine, PLoS ONE and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026